On this page, you can explore the sponsored tracks BII runs in collaboration with relevant industry collaborators. By collaborating with industrial players, BII extends its offerings to early-stage start-ups by providing even better access to commercial paths and industry-specific knowledge.
The Reproductive Medicine and Maternal Health Track
Through the Reproductive Medicine and Maternal Health Track, Ferring Pharmaceuticals A/S supports BII to source and potentially fund and incubate early-stage start-ups and projects within the field of reproductive medicine. For applicants, this is a unique opportunity to get direct early access to extensive expertise and advice from a key industry player.
Funding opportunity: Venture Lab
Are you looking for funding and professional guidance for your early-stage life science start-up? The Venture Lab program combines business acceleration, scientific development, and team development and includes a EUR 500,000 risk-free convertible loan.
We are looking for projects with evidence-based ideas and a clear understanding of unique value propositions. Applicants can be early-stage startups or researchers looking to take their research to a translational stage and build a start-up.
Read more about the program and apply for Venture Lab here.
Our focus areas
We are looking for therapeutics, diagnostics, or device solutions within the following areas:
If your project does not fall under these topics, check out the other topics supported in our women’s health initiative here.
The women’s health start-up Fimmcyte has already been supported under this track. Fimmcyte seeks to cure endometriosis, starting with a first step toward non-hormonal treatment of late-stage endometriosis. Read more about the first Ferring-sponsored project here.